Basel, Switzerland
July 24, 2009
First half
resilience: higher prices, successful risk management
-
Sales
$6.7 billion: up 2 percent CER(1), 9 percent
lower as reported
-
Crop
Protection sales up 1 percent(1) at $5.0 billion
-
Seeds
sales up 7 percent(1) to $1.7 billion
-
EBITDA
$2.0 billion, up 4 percent CER
-
Earnings per share(2) $15.18, 8 percent lower
-
Earnings per share $14.78 after restructuring and impairment
|
Reported Financial
Highlights |
|
Excluding Restructuring,
Impairment |
|
H1 2009
$m |
H1 2008
$m |
Actual
% |
|
H1 2009
$m |
H1 2008
$m |
Actual
% |
CER(1)
% |
Sales |
6,655 |
7,295 |
- 9 |
|
6,655 |
7,295 |
- 9 |
+2 |
Net Income(3) |
1,385 |
1,519 |
- 9 |
|
1,423 |
1,576 |
- 10 |
|
Earnings per share |
$14.78 |
$15.93 |
- 7 |
|
$15.18 |
$16.53 |
- 8 |
|
Mike Mack, Chief Executive Officer, said:
“In the first half of 2009 Syngenta achieved further underlying
sales growth following an exceptional year in 2008. This
performance, in the context of rigorous credit management in
emerging markets and generally adverse weather conditions in the
second quarter, attests to the strength of our portfolio and our
leading market positions. Price increases offset lower volumes
and higher raw material costs, although significant currency
movements impacted reported earnings. In Crop Protection, the
achievement of our target for price increases across the
business clearly demonstrates the value which our products offer
to growers. In Seeds, we saw growth across all product lines
led by Corn & Soybean, where the investments of recent years are
increasingly apparent in the quality of our technology. Seeds
profitability improved noticeably in the first half and we are
firmly on track to meet our target of a 15 percent EBITDA margin
for this business in 2011.
“We continue to make significant investments in order to secure
the long term growth of our business. We have expanded our R&D
network and are engaging in a number of collaborations and
cross-licensing agreements which will enable us to leverage our
unique technology platforms. Our capacity expansion program for
key Crop Protection compounds is well underway and will
reinforce our competitive strength in high margin segments. Our
investments are underpinned by a strong balance sheet, sustained
by the prudent management of our business in this year’s
uncertain economic environment.”
(1) Growth at constant exchange rates, see Appendix A.
(2) EPS on a fully-diluted basis, excluding restructuring and
impairment.
(3) Net income to shareholders of Syngenta AG.Financial
Performance 1st Half 2009
Sales $6.7
billion
Sales at
constant exchange rates (CER) increased by two percent driven by
higher pricing across all product lines. Crop Protection sales*
rose by one percent (CER) and Seeds sales by seven percent
(CER). Reported sales in US dollars were nine percent lower
owing to currency movements.
EBITDA
margin 30.5 percent
EBITDA was
$2.0 billion, an increase of four percent (CER). Profitability
improved in Seeds, while in Crop Protection price increases more
than offset higher raw material costs related to the oil price
escalation in 2008. Operational efficiency savings were
supplemented by strong cost control enabling further investment
in R&D. The underlying improvement in profitability was masked
by the appreciation of the dollar, which had a negative impact
on EBITDA of $349 million.
Earnings
per share $15.18
Price
increases across the business offset the impact of lower volume
and higher raw material costs. An eight percent decline in
earnings per share excluding restructuring and impairment was
due to currency movements. After charges for restructuring and
impairment, earnings per share were $14.78 (2008: $15.93).
Business
Highlights
Crop
Protection
In the first
half of 2009, Syngenta continued to demonstrate price
leadership, achieving an overall increase of seven percent,
ahead of target. Excluding glyphosate, prices were up by eight
percent. Sales volume was affected by a late start to the
season caused by unfavorable weather. In a number of emerging
markets, we deliberately reduced volume to take account of
higher levels of risk.
These risk
management measures had a marked impact in Eastern Europe,
Africa and the Middle East. Sales in Western Europe were
slightly up with a strong performance in France following new
product registrations. NAFTA showed robust sales
following an exceptional performance in 2008, with price
realization augmented by strong volume growth in Canada. Sales
in Latin America, where the main season takes place in
the second half, were lower due to drought in Argentina and
southern Brazil, and to risk management. In Asia-Pacific,
the farm economy has proved resilient to the global economic
crisis and sales continued to grow strongly across the region.
Product line
growth was led by Selective Herbicides, with strong
growth in cereal herbicides and a resurgence in demand for
soybean herbicides in the USA as a consequence of increased
acreage and weed resistance. Non-selective Herbicides
also performed well, with positive contributions from both
REGLONE® and TOUCHDOWN®. Accounting for
seven percent of Crop Protection sales, TOUCHDOWN®
showed modest growth in both volume and price, with pressures in
the US glyphosate market apparent only towards the end of the
period. Both Fungicides and Insecticides were
particularly affected by the risk management measures taken in
Latin America. In the Northern hemisphere, fungicide usage was
reduced owing to lower cereals acreage and adverse weather.
Seed Care sales continued to grow strongly driven by CRUISER®.
In the
non-agricultural Professional Products businesses, the
effects of the economic downturn were clearly apparent in the
golf course and professional horticulture segments, where
customers purchased more cautiously.
* Crop Protection sales include $26 million of inter-segment
sales.
New
products:
Sales of new products (defined as those launched since 2006)
increased by 28 percent (CER) to $241 million. AXIAL®
continued to grow strongly particularly in Canada. The roll-out
of REVUS® and DURIVO® in new markets
augmented underlying growth.
R&D
pipeline:
The combined peak sales potential of our Crop
Protection pipeline is in excess of $2 billion. We have several
new products in late development including INVINSA™, a unique
product for crop stress protection in field crops; isopyrazam
(520), a broad spectrum cereal fungicide; sedaxane (524), a seed
treatment fungicide; and bicyclopyrone (449), a new herbicide
for corn and sugar cane.
EBITDA
increased by one percent (CER) to $1.7 billion
with a margin (CER) of 36.6 percent (2008: 36.3 percent).
Seeds
Seeds growth
was driven by price increases of 11 percent, which reflected
ongoing increases in the value of the portfolio and more than
offset the impact of higher grower costs.
Performance
was led by Corn & Soybean, with growth in both NAFTA and
Asia more than offsetting the impact of risk management and
lower corn acreage in Eastern Europe and Latin America.
In the USA, although the market was characterized by delayed
planting decisions and acreage uncertainty, sales of our triple
stack corn seed AGRISURE® 3000 GT showed a
significant advance. Further advances in portfolio quality will
be achieved through stepping up combination of our proprietary
traits with elite germplasm.
Diverse
Field Crops
showed solid
growth across the business. Our risk management measures in
Eastern Europe resulted in improved collections, allowing the
expansion of sunflower sales in the second quarter in a market
moving towards higher quality hybrids. In the USA sales of
glyphosate-tolerant sugar beet continued to increase following
its successful launch last year.
Vegetables
& Flowers:
Growth in Vegetables reflected the ongoing expansion of high
value products such as peppers where the portfolio has been
enhanced both through acquisitions and through in-house marker
assisted breeding success. Flowers growth was due to the
consolidation of Goldsmith Seeds Inc. and Yoder, with the
underlying business affected by the downturn in consumer
purchasing.
R&D
pipeline:
In February Syngenta received EPA approval
for two insecticidal trait stacks containing its Agrisure
Viptera™ trait. Agrisure Viptera™ controls a broad spectrum of
lepidopteran corn pests and is awaiting USDA approval which
would allow an initial launch by the end of the year.
In April,
Syngenta and Dow AgroSciences announced an agreement to
cross-license their respective corn traits for commercialization
within their branded seed businesses. The agreement will allow
Syngenta, from 2011, to offer its US customers multiple modes of
action targeting refuge reduction and improved efficacy.
Syngenta’s
corn and soybean pipelines contain a number of other products
including input, output and agronomic traits, with a combined
peak sales potential of around $2 billion.
EBITDA
of $314 million, up 31 percent (CER), was driven by portfolio
transformation and the leverage of R&D and marketing
expenditure. The EBITDA margin (CER) improved to 19.2 percent
(2008: 15.6 percent) and is on track to reach the full year
target of 15 percent in 2011.
Net
financial expense
Net financial
expense at $46 million was slightly higher compared with the
first half of 2008 ($37 million).
Taxation
The underlying
tax rate for the period was 19 percent, in line with the rate
for the full year 2008. A similar rate is expected for the full
year 2009. The expected tax rate over the medium term is in the
low to mid-twenties.
Cash flow
Free cash flow
was $79 million (2008: $240 million). Fixed capital expenditure
of $283 million (2008: $168 million) reflected spending under
the capacity expansion program for key active ingredients
announced in 2008. Average trade working capital as a
percentage of sales was 40 percent (2008: 36 percent) as
inventories increased compared with an exceptionally low level
in 2008. Ongoing strong receivables management and business
seasonality are expected to lead to significant free cash flow
in the second half.
Cash return
to shareholders
A dividend of
CHF 6.00 per share (2008: CHF 4.80) was paid in the second
quarter, representing a total payout of $491 million.
Outlook
Mike Mack,
Chief Executive Officer, said:
“I am pleased
with the resilience of the company’s first half performance in
the face of currency and raw material headwinds and the second
quarter impact of a late spring. We maintained our focus on
rigorous risk management throughout the period in order to
preserve balance sheet quality. For the full year, achieving
earnings growth has become more challenging. However, in the
second half currency and raw material trends are more favorable
and, assuming current supportive conditions in Latin America
continue, we are targeting full year earnings per share* close
to the record level achieved in 2008.
“We look ahead
with confidence. The fundamental drivers for our industry are
unchanged, and we expect the need for increased global food
production to result in ongoing demand growth, which our broad
portfolio is uniquely placed to capture.”
Full version /
Volle Version /
Version complète (PDF) |